Acquisitions (Schedule Of Revenue And Income And Net Loss Included In Condensed Consolidated Statements of Operations) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Revenue	$ 2,090	$ 30,232	$ 56,928	$ 32,204
Net (loss) income attributable to Endo International plc ordinary shareholders	(252,084)	40,223	(667,836)	90,571
Basic net income per share (usd per share)	$ (1.64)	$ 0.35	$ (4.62)	$ 0.80
Diluted net income per share (usd per share)	$ (1.64)	$ 0.33	$ (4.62)	$ 0.77
Paladin Labs Inc. [Member]
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Revenue			165,852
Net (loss) income attributable to Endo International plc ordinary shareholders			$ 15,201
Basic net income per share (usd per share)			$ 0.11
Diluted net income per share (usd per share)			$ 0.11